Encision, Inc. (ECIA)
Stock Price:
$0.560 USD
0.000 (0.00%)
Updated Oct 16, 2020 9:30 AM EDT - Market closed
Key Info
| Market Cap |
6.49M |
| Revenue (ttm) |
7.09M |
| Net Income (ttm) |
-155,723 |
| Shares Out |
11.58M |
| EPS (ttm) |
-0.01 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 16, 2020 |
| Last Price |
$0.560 |
| Previous Close |
$0.560 |
| Change ($) |
0.000 |
| Change (%) |
0.00% |
| Day's Open |
0.560 |
| Day's Range |
0.560 - 0.560 |
| Day's Volume |
0 |
| 52-Week Range |
0.35 - 0.75 |
More Stats
| Market Cap |
6.49M |
| Enterprise Value |
6.64M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
11.58M |
| Float |
6.32M |
| EPS (basic) |
-0.01 |
| EPS (diluted) |
-0.01 |
| FCF / Share |
-0.01 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
3,189 |
| Short Ratio |
0.49 |
| Short % of Float |
0.05% |
| Beta |
-0.43 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
0.91 |
| PB Ratio |
3.16 |
| Revenue |
7.09M |
| Operating Income |
-126,545 |
| Net Income |
-155,723 |
| Free Cash Flow |
-130,239 |
| Net Cash |
-154,105 |
| Net Cash / Share |
-0.01 |
| Gross Margin |
56.47% |
| Operating Margin |
-1.79% |
| Profit Margin |
-2.20% |
| FCF Margin |
-1.84% |
| ROA |
-1.70% |
| ROE |
-7.36% |
| ROIC |
-3.00% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 7.67 | 8.80 | 8.75 | 8.87 | 9.34 | 9.67 | 10.55 | 11.77 | 12.99 | 11.62 |
| Revenue Growth | -12.86% | 0.55% | -1.3% | -5% | -3.47% | -8.3% | -10.37% | -9.41% | 11.81% | - |
| Gross Profit | 4.00 | 4.67 | 5.01 | 4.41 | 4.58 | 4.69 | 4.38 | 6.53 | 7.03 | 7.21 |
| Operating Income | -0.16 | -0.19 | 0.40 | -0.69 | -0.71 | -1.18 | -1.51 | -0.55 | -0.47 | 0.05 |
| Net Income | -0.20 | -0.24 | 0.34 | -0.73 | -0.88 | -1.38 | -1.78 | -0.62 | -0.53 | - |
| Shares Outstanding | 11.57 | 10.93 | 10.68 | 10.68 | 10.67 | 10.67 | 8.92 | 8.20 | 6.46 | 6.46 |
| Earnings Per Share | -0.02 | -0.02 | 0.03 | -0.07 | -0.08 | -0.13 | -0.20 | -0.08 | -0.08 | - |
| Operating Cash Flow | -0.23 | -0.13 | 0.42 | 0.02 | -0.17 | -1.43 | 0.11 | -0.32 | 0.16 | 0.20 |
| Capital Expenditures | -0.05 | -0.06 | -0.06 | -0.11 | -0.08 | -0.03 | -0.42 | -0.30 | -0.70 | -0.27 |
| Free Cash Flow | -0.28 | -0.18 | 0.36 | -0.08 | -0.24 | -1.46 | -0.31 | -0.62 | -0.54 | -0.07 |
| Cash & Equivalents | 0.39 | 0.30 | 0.14 | 0.10 | 0.32 | 0.26 | 1.69 | 0.13 | 0.56 | 0.12 |
| Total Debt | 0.37 | - | - | 0.28 | 0.39 | 0.06 | 0.12 | - | - | 0.44 |
| Net Cash / Debt | 0.01 | 0.30 | 0.14 | -0.18 | -0.07 | 0.19 | 1.57 | 0.13 | 0.56 | -0.31 |
| Assets | 4.74 | 3.43 | 3.25 | 3.07 | 3.81 | 4.73 | 6.21 | 5.98 | 6.41 | 5.41 |
| Liabilities | 2.55 | 1.08 | 1.05 | 1.26 | 1.35 | 1.46 | 1.62 | 1.59 | 1.67 | 1.66 |
| Book Value | 2.18 | 2.35 | 2.20 | 1.80 | 2.46 | 3.27 | 4.59 | 4.39 | 4.74 | 3.75 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Encision, Inc. |
| Country |
United States |
| Employees |
30 |
| CEO |
Gregory J. Trudel |
Stock Information
| Ticker Symbol |
ECIA |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
OTCMKTS: ECIA |
| IPO Date |
June 25, 1996 |
Description
Encision, a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. It sells its products through a network of direct and independent sales representatives. The company was founded in 1991 and is based in Boulder, Colorado.